Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 1,001–1,045 of 1,045 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05019690	Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer	recruiting	Phase 1 / Phase 2	29	Fujian Cancer HospitalOTHER_GOV	1	Sep 19, 2024	clinicaltrials
NCT06527898	Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer	recruiting	Phase 1 / Phase 2	45	Anhui Provincial HospitalOTHER_GOV	1	Sep 19, 2024	clinicaltrials